Product Information
XTAMPZA ER 9 MG CAPSULE is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $6.1057 per EA under NDC 24510011010. Its NADAC has been published 399 times since May 17, 2017.
Strength
9 mg/1
Manufacturer
Collegium Pharmaceutical, Inc.NDC
24510011010
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
12/18/2024
Active Ingredients
OXYCODONEApproval Type
New Drug (NDA)
FDA Application
NDA208090On Market Since
5/10/2016
Pharmacological Classes
Price Statistics
The NADAC for XTAMPZA ER 9 MG CAPSULE has been published 399 times since May 17, 2017, and over the history we have for it it has risen 76.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1057 per EA |
|---|---|
| All-time high | $6.1068 (Sep 11, 2024) |
| All-time low | $3.4700 (May 17, 2017) |
| Median price | $5.1553 |
| Average price | $4.9792 |
| Largest weekly change | +9.9% (Jan 9, 2019) |
| Weeks tracked | 399 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXYCODONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XTAMPZA ER 9 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for XTAMPZA ER 9 MG CAPSULE, manufactured by Collegium Pharmaceutical, Inc., is $6.1057 per EA (NDC 24510011010), effective Jan 1, 2025.
How has the price of XTAMPZA ER 9 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for XTAMPZA ER 9 MG CAPSULE has risen 76.0%. It has been tracked across 399 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for XTAMPZA ER 9 MG CAPSULE?
Since May 17, 2017, the NADAC for XTAMPZA ER 9 MG CAPSULE has ranged from a low of $3.4700 (May 17, 2017) to a high of $6.1068 (Sep 11, 2024), with a median of $5.1553 per EA.
Are there cheaper alternatives to XTAMPZA ER 9 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XTAMPZA ER 9 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures XTAMPZA ER 9 MG CAPSULE?
XTAMPZA ER 9 MG CAPSULE (NDC 24510011010) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification